Zebita XT Tablet is a pharmaceutical formulation containing Ferrous Ascorbate 100 mg and Folic Acid 1.5 mg, primarily indicated for the prevention and treatment of iron deficiency anemia and folate deficiency. Ferrous Ascorbate serves as a bioavailable source of elemental iron, facilitating hemoglobin synthesis and improving oxygen transport in the blood. Folic Acid, a vital B-vitamin, plays a crucial role in DNA synthesis, red blood cell formation, and cellular growth, thereby complementing iron therapy in anemic conditions. This combination is particularly beneficial in populations with increased iron and folate requirements such as pregnant and lactating women, individuals with nutritional deficiencies, and patients recovering from blood loss. Zebita XT enhances hematological parameters by replenishing depleted iron stores and correcting folate insufficiency, thereby improving overall hematopoiesis. The tablet is generally well tolerated; however, common adverse effects may include gastrointestinal discomfort, nausea, constipation, or diarrhea. It is recommended to administer Zebita XT with food to minimize gastrointestinal irritation. Caution is advised in patients with hemochromatosis, hypersensitivity to any component, or severe hepatic or renal impairment. Regular monitoring of hemoglobin levels and iron status is essential during prolonged therapy to avoid iron overload. Zebita XT Tablet should be used under medical supervision to ensure optimal therapeutic outcomes.